TE_7292
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1P1_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | GAP43, ENSG00000242880 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 159.30 |
| Counts of samples | TCGA_tumor:423; TCGA_normal:0; GTEx:2 |
| TSS | chr3(+):115318081 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_7292.11 | GAP43 | Chimeric | Non-coding | Non-coding | chr3(+):115318082,115318144,115318312,115318507,115676013,115676610,115720794,115720814 |
| teRNA_7292.12 | GAP43 | Chimeric | Non-coding | Non-coding | chr3(+):115318082,115318124,115318241,115318507,115676013,115676610,115720794,115720814 |
| teRNA_7292.13 | ENSG00000242880 | Chimeric | Non-coding | Non-coding | chr3(+):115318082,115318124,115318241,115318507,115370059,115370079 |
| teRNA_7292.14 | ENSG00000242880 | Chimeric | Non-coding | Non-coding | chr3(+):115318082,115318124,115318241,115318507,115334017,115334037 |
| teRNA_7292.15 | GAP43 | Chimeric | Non-coding | Non-coding | chr3(+):115318082,115318124,115318312,115318507,115676013,115676610,115720794,115720814 |
| teRNA_7292.16 | ENSG00000242880 | Chimeric | Non-coding | Non-coding | chr3(+):115318082,115318124,115318312,115318507,115370059,115370079 |
| teRNA_7292.17 | ENSG00000242880 | Chimeric | Non-coding | Non-coding | chr3(+):115318082,115318210,115318358,115318507,115370059,115370079 |
| teRNA_7292.18 | GAP43 | Chimeric | Non-coding | Non-coding | chr3(+):115318082,115318210,115318358,115318507,115676013,115676610,115720794,115720814 |
| teRNA_7292.19 | ENSG00000242880 | Chimeric | Non-coding | Non-coding | chr3(+):115318082,115318210,115318358,115318507,115334017,115334037 |
| teRNA_7292.20 | ENSG00000242880 | Chimeric | Non-coding | Non-coding | chr3(+):115318082,115318124,115318362,115318507,115370059,115370079 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
